Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta2‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐acting Muscarinic Antagonists (LAMA) Added to Combination Long‐acting Beta2‐agonists and Inhaled Corticosteroids (LABA/ICS) Versus LABA/ICS for Adults With Asthma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432170/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_combination_long‐acting_beta2‐agonists_and_inhaled_corticosteroids__LABA_ICS__versus_LABA_ICS_for_adults_with_asthma.
Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta2‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432170/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_combination_long‐acting_beta2‐agonists_and_inhaled_corticosteroids__LABA_ICS__versus_LABA_ICS_for_adults_with_asthma. Accessed February 8, 2025.
Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta2‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432170/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_combination_long‐acting_beta2‐agonists_and_inhaled_corticosteroids__LABA_ICS__versus_LABA_ICS_for_adults_with_asthma
Long‐acting Muscarinic Antagonists (LAMA) Added to Combination Long‐acting Beta2‐agonists and Inhaled Corticosteroids (LABA/ICS) Versus LABA/ICS for Adults With Asthma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432170/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_combination_long‐acting_beta2‐agonists_and_inhaled_corticosteroids__LABA_ICS__versus_LABA_ICS_for_adults_with_asthma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta2‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
ID - 432170
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432170/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_combination_long‐acting_beta2‐agonists_and_inhaled_corticosteroids__LABA_ICS__versus_LABA_ICS_for_adults_with_asthma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -